NATIONWIDE – Maine’s junior U.S. Senator — Independent Angus King — and a group of colleagues are pushing the National Institute of Allergy and Infectious Diseases to provide an update on research to develop a universal flu vaccine.
Last year, the institute released its plan to achieve a universal flu vaccine, which would be at least 75 percent effective, protect against multiple flu strains, provide protection for at least one year, and be appropriate for all ages.
In a letter to the institute, the senators stated: “The sooner we can achieve a universal vaccine, the sooner we can reduce the relentless burden the flu places on American families each year.”
The senators asked for a response to a number of inquiries.
“Congress is committed to helping actualize that plan and achieve the mutual goal of putting a universal flu vaccine on the market as soon as possible,” they wrote.